Edition:
United Kingdom

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

2.45USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,201
52-wk High
$37.50
52-wk Low
$1.64

Chart for

About

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based... (more)

Overall

Beta: 3.34
Market Cap(Mil.): $53.11
Shares Outstanding(Mil.): 32.18
Dividend: --
Yield (%): --

Financials

  NVIV.OQ Industry Sector
P/E (TTM): -- 196.85 33.64
EPS (TTM): -0.76 -- --
ROI: -83.17 9.70 14.27
ROE: -86.11 15.72 15.99

BRIEF-Invivo Therapeutics Reports Q1 Loss Per Share Of $3.34

* INVIVO THERAPEUTICS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS

07 May 2018

BRIEF-Invivo Therapeutics Files For Offering Of Up To $8 Mln Shares

* INVIVO THERAPEUTICS HOLDINGS CORP FILES FOR OFFERING OF UP TO $8 MILLION SHARES OF COMMON STOCK, WARRANTS TO PURCHASE SHARES OF COMMON STOCK - SEC FILING Source text (https://bit.ly/2HrYEIM) Further company coverage:

24 Apr 2018

Earnings vs. Estimates